Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan
· Delayed Price · Currency is TWD 175.50
+0.50 (0.29%)
Feb 14, 2025, 9:00 AM CST
TPEX:6712 Revenue
Ever Supreme Bio Technology had revenue of 248.13M TWD in the quarter ending September 30, 2024, with 9.39% growth. This brings the company's revenue in the last twelve months to 844.86M, up 23.67% year-over-year. In the year 2023, Ever Supreme Bio Technology had annual revenue of 758.39M with 20.86% growth.
Revenue (ttm)
844.86M
Revenue Growth
+23.67%
P/S Ratio
17.85
Revenue / Employee
n/a
Employees
n/a
Market Cap
15.21B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 16.71B |
| Lotus Pharmaceutical | 17.59B |
| Lumosa Therapeutics | 37.82M |
| Oneness Biotech | 112.20M |
| Polaris Group | 75.65M |
| Pegavision | 7.06B |